Newsbenzinga
Radiopharm Theranostics Announces Completion Of EOP2 Meeting With FDA Regarding RAD101, Investigational Radiopharmaceutical Imaging Agent For Detection Of Brain Metastases
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…